Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana

Authors: Christopher Pell, Arantza Meñaca, Samuel Chatio, Abraham Hodgson, Harry Tagbor, Robert Pool

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

Affecting mother and child, malaria during pregnancy (MiP) provokes a double morbidity and mortality burden. Within a package of interventions to prevent MiP in endemic areas, the WHO currently recommends intermittent preventive treatment (IPTp). Concerns about anti-malarial resistance have however prompted interest in intermittent screening and treating (IST) as an alternative approach to IPTp. IST involves screening for malaria infection at scheduled antenatal care (ANC) clinic visits and treating malaria cases. In light of the need to comprehensively evaluate new interventions prior to roll out, this article explores the acceptability of IST with artemether-lumefantrine (AL) compared to IPTp with sulphadoxine-pyrimethamine (SP) and in Upper East Region, northern Ghana.

Methods

Data were collected alongside an open-label, randomized, controlled trial of IST-AL and IPTp-SP in Kassena-Nankana District. Thirty pregnant women enrolled in the clinical trial participated in six focus group discussions. Ten in-depth interviews were carried out with clinical trial staff. Observations were also made at the health facilities where the clinical trial took place.

Results

Trial participants were generally willing to endure the discomfort of the finger prick necessary for a rapid diagnostic test for malaria and this reflected a wider demand for diagnostic techniques. Reports of side effects were however linked to both trial anti-malarials. Direct complaints about SP were particularly severe with regard to women’s experience of vomiting. Although the follow-up treatment doses of AL for IST were not supervised, based on blister inspection and questioning trial, staff were confident about participants’ adherence to the treatment course. One case of partial adherence to the AL treatment course was reported.

Conclusion

Despite the discomfort of the finger prick required to perform the intermittent malaria screening, trial participants generally expressed more positive sentiments towards IST-AL than IPTp-SP. Nonetheless, questions remain about adherence to a multiple dose anti-malarial regimen during pregnancy, particularly in endemic areas where MiP is often non-symptomatic. Any implementation of IST must be accompanied by appropriate health messages on adherence and the necessary training for health staff regarding case management.
Literature
1.
go back to reference Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.CrossRefPubMed Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.CrossRefPubMed
2.
go back to reference Menendez C, D’Alessandro U, ter Kuile FO: Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007, 7: 126-135. 10.1016/S1473-3099(07)70024-5.CrossRefPubMed Menendez C, D’Alessandro U, ter Kuile FO: Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007, 7: 126-135. 10.1016/S1473-3099(07)70024-5.CrossRefPubMed
3.
go back to reference Guyatt HL, Snow RW: Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004, 17: 760-769. 10.1128/CMR.17.4.760-769.2004.PubMedCentralCrossRefPubMed Guyatt HL, Snow RW: Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004, 17: 760-769. 10.1128/CMR.17.4.760-769.2004.PubMedCentralCrossRefPubMed
4.
go back to reference WHO: World Malaria Report 2012. 2012, Geneva, Switzerland: World Health Organization WHO: World Malaria Report 2012. 2012, Geneva, Switzerland: World Health Organization
5.
go back to reference WHO: Guidelines for the Treatment of Malaria, 2010. 2010, Geneva, Switzerland: World Health Organization, 194- WHO: Guidelines for the Treatment of Malaria, 2010. 2010, Geneva, Switzerland: World Health Organization, 194-
6.
go back to reference WHO: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. 2004, Regional Office for Africa: World Health Organization WHO: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. 2004, Regional Office for Africa: World Health Organization
7.
go back to reference Parikh S, Rosenthal P: Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine–pyrimethamine the right drug?. Clin Pharmacol Ther. 2010, 87: 160-162. 10.1038/clpt.2009.284.CrossRefPubMed Parikh S, Rosenthal P: Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine–pyrimethamine the right drug?. Clin Pharmacol Ther. 2010, 87: 160-162. 10.1038/clpt.2009.284.CrossRefPubMed
8.
go back to reference World Health Organization: Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp). 2007, Geneva: WHO headquarters World Health Organization: Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp). 2007, Geneva: WHO headquarters
9.
go back to reference Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis. 2007, 7: 145-10.1016/S1473-3099(07)70026-9.CrossRefPubMed Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis. 2007, 7: 145-10.1016/S1473-3099(07)70026-9.CrossRefPubMed
10.
go back to reference Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U: Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008, 198: 1545-1549. 10.1086/592455.CrossRefPubMed Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U: Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008, 198: 1545-1549. 10.1086/592455.CrossRefPubMed
11.
go back to reference Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE. 2010, 5: e14425-10.1371/journal.pone.0014425.PubMedCentralCrossRefPubMed Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE. 2010, 5: e14425-10.1371/journal.pone.0014425.PubMedCentralCrossRefPubMed
12.
go back to reference Smith L, Jones C, Adjei R, Antwi G, Afrah N, Greenwood B, Chandramohan D, Tagbor H, Webster J: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010, 9: 18-10.1186/1475-2875-9-18.PubMedCentralCrossRefPubMed Smith L, Jones C, Adjei R, Antwi G, Afrah N, Greenwood B, Chandramohan D, Tagbor H, Webster J: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010, 9: 18-10.1186/1475-2875-9-18.PubMedCentralCrossRefPubMed
13.
go back to reference Mbonye AK, Neema S, Magnussen P: Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda. Health Policy. 2006, 77: 279-289. 10.1016/j.healthpol.2005.07.020.CrossRefPubMed Mbonye AK, Neema S, Magnussen P: Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda. Health Policy. 2006, 77: 279-289. 10.1016/j.healthpol.2005.07.020.CrossRefPubMed
14.
go back to reference Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania. Malar J. 2005, 4: 31-10.1186/1475-2875-4-31.PubMedCentralCrossRefPubMed Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania. Malar J. 2005, 4: 31-10.1186/1475-2875-4-31.PubMedCentralCrossRefPubMed
15.
go back to reference Mushi AK, Schellenberg J, Mrisho M, Manzi F, Mbuya C, Mponda H, Mshinda H, Tanner M, Alonso P, Pool R, Schellenberg D: Development of behaviour change communication strategy for a vaccination-linked malaria control tool in Southern Tanzania. Malar J. 2008, 7: 191-10.1186/1475-2875-7-191.PubMedCentralCrossRefPubMed Mushi AK, Schellenberg J, Mrisho M, Manzi F, Mbuya C, Mponda H, Mshinda H, Tanner M, Alonso P, Pool R, Schellenberg D: Development of behaviour change communication strategy for a vaccination-linked malaria control tool in Southern Tanzania. Malar J. 2008, 7: 191-10.1186/1475-2875-7-191.PubMedCentralCrossRefPubMed
16.
go back to reference Brabin L, Stokes E, Dumbaya I, Owens S: Gambian women’s reliance on health workers to deliver sulphadoxine-pyrimethamine as recommended intermittent preventive treatment for malaria in pregnancy. Malar J. 2009, 8: 25-10.1186/1475-2875-8-25.PubMedCentralCrossRefPubMed Brabin L, Stokes E, Dumbaya I, Owens S: Gambian women’s reliance on health workers to deliver sulphadoxine-pyrimethamine as recommended intermittent preventive treatment for malaria in pregnancy. Malar J. 2009, 8: 25-10.1186/1475-2875-8-25.PubMedCentralCrossRefPubMed
17.
go back to reference Mbonye AK, Bygbjerg I, Magnussen P: Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda. Health Policy. 2007, 81: 228-241. 10.1016/j.healthpol.2006.05.018.CrossRefPubMed Mbonye AK, Bygbjerg I, Magnussen P: Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda. Health Policy. 2007, 81: 228-241. 10.1016/j.healthpol.2006.05.018.CrossRefPubMed
18.
go back to reference Pell C, Menaca A, Afrah NA, Manda-Taylor L, Chatio S, Were F, Hodgson A, Hamel MJ, Kalilani L, Tagbor H, Pool R: Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J. 2013, 12: 427-10.1186/1475-2875-12-427.PubMedCentralCrossRefPubMed Pell C, Menaca A, Afrah NA, Manda-Taylor L, Chatio S, Were F, Hodgson A, Hamel MJ, Kalilani L, Tagbor H, Pool R: Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J. 2013, 12: 427-10.1186/1475-2875-12-427.PubMedCentralCrossRefPubMed
20.
go back to reference Pell C, Straus L, Andrew EVW, Menaca A, Pool R: Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE. 2011, 6: e22452-10.1371/journal.pone.0022452.PubMedCentralCrossRefPubMed Pell C, Straus L, Andrew EVW, Menaca A, Pool R: Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE. 2011, 6: e22452-10.1371/journal.pone.0022452.PubMedCentralCrossRefPubMed
21.
go back to reference Pell C, Meñaca A, Were F, Afrah NA, Chatio S, Manda-Taylor L, Hamel MJ, Hodgson A, Tagbor H, Kalilani L: Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One. 2013, 8: e53747-10.1371/journal.pone.0053747.PubMedCentralCrossRefPubMed Pell C, Meñaca A, Were F, Afrah NA, Chatio S, Manda-Taylor L, Hamel MJ, Hodgson A, Tagbor H, Kalilani L: Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One. 2013, 8: e53747-10.1371/journal.pone.0053747.PubMedCentralCrossRefPubMed
22.
go back to reference Menaca A, Pell C, Manda L, Chatio S, Afrah NA, Were F, Hodgson A, Ouma P, Kalilani L, Tagbor H, Pool R: Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study. Malar J. 2013, 12: 257-10.1186/1475-2875-12-257.PubMedCentralCrossRefPubMed Menaca A, Pell C, Manda L, Chatio S, Afrah NA, Were F, Hodgson A, Ouma P, Kalilani L, Tagbor H, Pool R: Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study. Malar J. 2013, 12: 257-10.1186/1475-2875-12-257.PubMedCentralCrossRefPubMed
23.
go back to reference Ghana Statistical Service - Office of the President: Ghana - Population and Housing Census 2000. 2008 Ghana Statistical Service - Office of the President: Ghana - Population and Housing Census 2000. 2008
24.
go back to reference Bardají A, Bassat Q, Alonso PL, Menéndez C: Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence. Expert Opin Pharmacother. 2012, 13: 1719-1736. 10.1517/14656566.2012.703651.CrossRefPubMed Bardají A, Bassat Q, Alonso PL, Menéndez C: Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence. Expert Opin Pharmacother. 2012, 13: 1719-1736. 10.1517/14656566.2012.703651.CrossRefPubMed
25.
go back to reference Ghana Statistical Service - Office of the President: 2000 Population and Housing Census. 2002 Ghana Statistical Service - Office of the President: 2000 Population and Housing Census. 2002
26.
go back to reference Oduro AR, Wak G, Azongo D, Debpuur C, Wontuo P, Kondayire F, Welaga P, Bawah A, Nazzar A, Williams J: Profile of the Navrongo Health and Demographic Surveillance System. Int J Epidemiol. 2012, 41: 968-976. 10.1093/ije/dys111.CrossRefPubMed Oduro AR, Wak G, Azongo D, Debpuur C, Wontuo P, Kondayire F, Welaga P, Bawah A, Nazzar A, Williams J: Profile of the Navrongo Health and Demographic Surveillance System. Int J Epidemiol. 2012, 41: 968-976. 10.1093/ije/dys111.CrossRefPubMed
27.
go back to reference Ansah EK, Reynolds J, Akanpigbiam S, Whitty CJ, Chandler CI: “Even if the test result is negative, they should be able to tell us what is wrong with us”: a qualitative study of patient expectations of rapid diagnostic tests for malaria. Malar J. 2013, 12: 258-10.1186/1475-2875-12-258.PubMedCentralCrossRefPubMed Ansah EK, Reynolds J, Akanpigbiam S, Whitty CJ, Chandler CI: “Even if the test result is negative, they should be able to tell us what is wrong with us”: a qualitative study of patient expectations of rapid diagnostic tests for malaria. Malar J. 2013, 12: 258-10.1186/1475-2875-12-258.PubMedCentralCrossRefPubMed
28.
go back to reference Baiden F, Owusu-Agyei S, Okyere E, Tivura M, Adjei G, Chandramohan D, Webster J: Acceptability of rapid diagnostic test-based management of malaria among caregivers of under-five children in rural Ghana. PLoS One. 2012, 7: e45556-10.1371/journal.pone.0045556.PubMedCentralCrossRefPubMed Baiden F, Owusu-Agyei S, Okyere E, Tivura M, Adjei G, Chandramohan D, Webster J: Acceptability of rapid diagnostic test-based management of malaria among caregivers of under-five children in rural Ghana. PLoS One. 2012, 7: e45556-10.1371/journal.pone.0045556.PubMedCentralCrossRefPubMed
29.
go back to reference Hill J, D’Mello-Guyett L, Hoyt J, van Eijk AM, ter Kuile FO, Webster J: Women’s access and provider practices for the case management of malaria during pregnancy: a systematic review and meta-analysis. PLoS Med. 2014, 11: e1001688-10.1371/journal.pmed.1001688.PubMedCentralCrossRefPubMed Hill J, D’Mello-Guyett L, Hoyt J, van Eijk AM, ter Kuile FO, Webster J: Women’s access and provider practices for the case management of malaria during pregnancy: a systematic review and meta-analysis. PLoS Med. 2014, 11: e1001688-10.1371/journal.pmed.1001688.PubMedCentralCrossRefPubMed
30.
go back to reference Ghana Health Service (GHS): Guidelines for Malaria in Pregnancy. Ghana Health Service (GHS): Guidelines for Malaria in Pregnancy.
31.
go back to reference Chandler CI, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ: Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J. 2008, 7: 53-10.1186/1475-2875-7-53.PubMedCentralCrossRefPubMed Chandler CI, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ: Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J. 2008, 7: 53-10.1186/1475-2875-7-53.PubMedCentralCrossRefPubMed
32.
go back to reference Chandler CI, Mangham L, Njei AN, Achonduh O, Mbacham WF, Wiseman V: ‘As a clinician, you are not managing lab results, you are managing the patient’: How the enactment of malaria at health facilities in Cameroon compares with new WHO guidelines for the use of malaria tests. Soc Sci Med. 2012, 74: 1528-1535. 10.1016/j.socscimed.2012.01.025.CrossRefPubMed Chandler CI, Mangham L, Njei AN, Achonduh O, Mbacham WF, Wiseman V: ‘As a clinician, you are not managing lab results, you are managing the patient’: How the enactment of malaria at health facilities in Cameroon compares with new WHO guidelines for the use of malaria tests. Soc Sci Med. 2012, 74: 1528-1535. 10.1016/j.socscimed.2012.01.025.CrossRefPubMed
33.
go back to reference Paintain LS, Antwi GD, Jones C, Amoako E, Adjei RO, Afrah NA, Greenwood B, Chandramohan D, Tagbor H, Webster J: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS ONE. 2011, 6: e24035-10.1371/journal.pone.0024035.CrossRef Paintain LS, Antwi GD, Jones C, Amoako E, Adjei RO, Afrah NA, Greenwood B, Chandramohan D, Tagbor H, Webster J: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS ONE. 2011, 6: e24035-10.1371/journal.pone.0024035.CrossRef
34.
go back to reference Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed
35.
go back to reference Mace KE, Mwandama D, Jafali J, Luka M, Filler SJ, Sande J, Ali D, Kachur SP, Mathanga DP, Skarbinski J: Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi. Clin Infect Dis. 2011, 53: 772-779. 10.1093/cid/cir498.CrossRefPubMed Mace KE, Mwandama D, Jafali J, Luka M, Filler SJ, Sande J, Ali D, Kachur SP, Mathanga DP, Skarbinski J: Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi. Clin Infect Dis. 2011, 53: 772-779. 10.1093/cid/cir498.CrossRefPubMed
36.
go back to reference Lemma H, Lofgren C, San Sebastian M: Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia. Malar J. 2011, 10: 349-10.1186/1475-2875-10-349.PubMedCentralCrossRefPubMed Lemma H, Lofgren C, San Sebastian M: Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia. Malar J. 2011, 10: 349-10.1186/1475-2875-10-349.PubMedCentralCrossRefPubMed
37.
go back to reference Kabanywanyi AM, Lengeler C, Kasim P, King‘eng’ena S, Schlienger R, Mulure N, Genton B: Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J. 2010, 9: 48-10.1186/1475-2875-9-48.PubMedCentralCrossRefPubMed Kabanywanyi AM, Lengeler C, Kasim P, King‘eng’ena S, Schlienger R, Mulure N, Genton B: Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J. 2010, 9: 48-10.1186/1475-2875-9-48.PubMedCentralCrossRefPubMed
38.
go back to reference Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010, 7: e1000221-10.1371/journal.pmed.1000221.PubMedCentralCrossRefPubMed Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010, 7: e1000221-10.1371/journal.pmed.1000221.PubMedCentralCrossRefPubMed
Metadata
Title
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana
Authors
Christopher Pell
Arantza Meñaca
Samuel Chatio
Abraham Hodgson
Harry Tagbor
Robert Pool
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-432

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.